References
1. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.JAMA2013;310:591-608.
2. Hoy D, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum2012;64:2028-37.
3. Juniper M, Le T, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother2009;10:2581-92.
4. Cohen SP, Mao J. Mechanisms of neuropathic pain and their clinical implications. . BMJ2014;348:f7656.
5. Manusov EG (September 2012). "Evaluation and diagnosis of low back pain". Prim. Care 39 (3): 4719. doi:10.1016/j.pop.2012.06.003.PMID 22958556.
6. Cohen SP, Argoff CE, Carragee EJ (2008). "Management of low back pain". BMJ337: a2718. doi:10.1136/bmj.a2718. PMID 19103627
7. Koes, BW; van Tulder, M; Lin, CW; Macedo, LG; McAuley, J; Maher, C (December 2010). "An updated overview of clinical guidelines for the management of non-specific low back pain in primary care.". European Spine Journal 19 (12): 2075–94.doi:10.1007/s00586-010-1502-y. PMID 20602122
8. Manchikanti L, Falco FJ, Singh V, et al. Utilization of interventional techniques in managing chronic pain in the Medicare population: analysis of growth patterns from 2000 to 2011. Pain Physician2012;15:E969-82.
9. Cohen SP, Jamison D, Bicket M, et al. Epidural steroids: a comprehensive, evidence-based review. Reg Anesth Pain Med2013;38:175-200
10. Hopwood M, Abram S. Factors associated with failure of lumbar steroids. Reg Anes1993;18:238-43
11. Romano CL, Romanò D, Bonora C, et al Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthopaed Traumatol2009;10(4):185-91.
12. Baron R, Martin-Mola E, Müller M, et al. Effectiveness and safety of tapentadol prolonged release (PR) versus a combination of tapentadol PR and gabapentinfor the management of severe, chronic low back pain with a neuropathic component: a randomized, double-blind, phase 3b study. Pain Pract2014;doi:10.1111/papr.12200
13. Baron R, Freynhagen R, Tölle TR, et al; A0081007 Investigators. The efficacy and safety of gabapentinin the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain2010;150:420-7.
14. Pinto RZ, Maher CG, Ferreira ML, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med2012;157:865-77.
15. Brouwers MC, Thabane L, Moher D, et al. Comparative effectiveness research paradigm: implications for systematic reviews and clinical practice guidelines. J Clin Oncol2012;30:4202-7
16. Laiq N, Khan MN, Iqbal MJ, et al. Comparison of epidural steroid injections with conservative management in patients with lumbar radiculopathy. J Coll Physicians Surg Pak2009;19:539-43
17. Dincer U, Kiralp MZ, Cakar E, et al. Caudal epidural injection versus non-steroidal anti-inflammatory drugs in the treatment of low back pain accompanied with radicular pain. Joint Bone Spine2007;74:467-71
18. Cohen SP, Hayek S, Semenov Y, et al. Epidural steroid injections, conservative treatment or combination treatment for cervical radiculopathy: a multi-center, randomized, comparative-effectiveness study. Anesthesiology2014;121:1045-55.
19. Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD,et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med2014;371:11-21.
20. Steven P Cohen, Steven Hanling, Mark C Bicket, Ronald L White, Elias Veizi, Connie Kurihara et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study . BMJ 2015;350:h1748
DOI: http://dx.doi.org/10.18535/jmscr/v4i3.57
